Effect of Abemaciclib on Metformin Pharmacokinetics and Iohexol Clearance
Latest Information Update: 16 Jan 2020
At a glance
- Drugs Abemaciclib (Primary) ; Iohexol; Metformin
- Indications Brain cancer; Breast cancer; Cancer; Glioblastoma; Liposarcoma; Mantle-cell lymphoma; Non-small cell lung cancer; Pancreatic cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 24 Mar 2018 Results assessing Abemaciclib's effect on metformin pharmacokinetics and on iohexol clearance presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 23 Dec 2016 Status changed from recruiting to completed.
- 15 Sep 2016 New trial record